CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM NEW
Total 13F shares
1,565,589
Share change
-49,918
Total reported value
$9,378,000
Price per share
$5.99
Number of holders
21
Value change
-$301,480
Number of buys
7
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q1 2016

As of 31 Mar 2016, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,565,589 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, TAURUS ASSET MANAGEMENT, LLC, Moors & Cabot, Inc., Phocas Financial Corp., GEODE CAPITAL MANAGEMENT, LLC, THOMPSON DAVIS & CO., INC., RENAISSANCE TECHNOLOGIES LLC, and MORGAN STANLEY. This page lists 21 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.